| Ytd | 74.10% | |
| 1y | 56.25% |
| Open | 50.15 | Prev Close | 49.57 | Low | 49.38 | High | 52.22 | Mkt Cap | 4.41B |
| Vol | 6.61M | Avg Vol | 1.93M | EPS | -3.15 | P/E | N/A | Forward P/E | -197.24 |
| Beta | N/A | Short Ratio | 2.93 | Inst. Own | 91.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 36.85 | 200-d Avg | 30.66 | 1yr Est | 44.78 |
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s share price reached a new 52-week high during tra
Amundi bought a new stake in Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock i
The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of
American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both
UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and
The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufactu
Bank of New York Mellon Corp bought a new stake in shares of Heartflow, Inc. (NASDAQ: HTFL) during t
BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in the undefined quarter, acco
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonst
SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lea
The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The tr
HeartFlow delivered a convincing Q2 with 48% sales growth and gross margins rising to 83%, driving s
Heartflow's AI-powered platform could save countless lives. The company is growing at an impressive
HeartFlow Inc. (NASDAQ:HTFL) shares are trading sharply higher Friday afternoon after the company re
HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results a
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise
Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and rai
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular
Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises
JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises th
Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise
U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected ea
Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results
HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript
Heartflow NASDAQ: HTFL reported second-quarter revenue of $64.1 million, up 48% from a year earlier,
HeartFlow (HTFL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estima
HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thu
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session
HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.07) per share which beat the analyst consen
HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $246.0
SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lea
Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, init
Baird analyst David Rescott initiates coverage on HeartFlow (NASDAQ:HTFL) with a Outperform ratin
Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) wit
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and lower
Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise
HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $228.0
HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.16) per share which beat the analyst consen
Options markets are pricing post-earnings moves between 17.74% and 42.50% on ten small/mid caps repo
U.S. stocks drop, with Dow Jones down 150 points. Signet Jewelers stock rose 11.8% after beating ear